Description
GDC-0973 is a selective inhibitor of MEK1. When used intermittently with the PI3K inhibitor GDC-0941, GDC-0973 shows efficacy in the treatment of Braf and Kras mutant cancer cell lines.
Product Unit Size | Cost | Quantity | Stock |
---|
GDC-0973 is a selective inhibitor of MEK1. When used intermittently with the PI3K inhibitor GDC-0941, GDC-0973 shows efficacy in the treatment of Braf and Kras mutant cancer cell lines.
Cas No. | 934660-93-2 |
---|---|
Purity | ≥99% |
Formula | C21H21F3IN3O2 |
Formula Wt. | 531.32 |
IUPAC Name | {3,4-Difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}{3-hydroxy-3-[(2S)-2-piperidinyl]-1-azetidinyl}methanone |
Synonym | GDC 0973, GDC0973, XL-518, XL 518, XL518, Cobimetinib, RG-7420, RG 7420, RG7420 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Andrlova H., Zeiser R., et al. Cobimetinib (GDC-0973, XL518). Recent Results Cancer Res. 211:177-86 (2018). PMID:30069767.
Hoeflich K., Merchant M., et al. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. Cancer Res. 72(1):210-19 (2012). PMID: 22084396.
Non-selective HDAC inhibitor.
Synthetic steroid hormone, estrogen analog, use...
Penicillin derivative, chelating agent; carboxy...
Dibenzofuran produced by lichens.
Piperazine; 5-HT1 agonist, 5-HT2/3 and α2-adre...
Neutrophil elastase inhibitor.
Endogenous opioid peptide; μOr agonist.
Non-opioid analgesic.
Acridine derivative, DNA intercalator; topoisom...
FIASMA, 5-HT1/2, M1-5 mAChR, α1-adrenergic, hi...
Metabolite of clofibrate; PPARα agonist.
Polymixin, antimicrobial peptide, induces forma...
MEK1/2 inhibitor.
ITC.
Docetaxel impurity
Dual mTORC1/mTORC2 inhibitor.
EGFR inhibitor.
Trichothecene mycotoxin produced by Fusarium, a...
Thrombin inhibitor.
Inhibitor of TRK.